All patients showed absent or decreased expression of dystrophin on immunohistochemical staining, proving the effectiveness of NGS combined with MLPA in the diagnoses of dystrophinopathies[38, 39]. The gene discussed is DMD; the disease is neuromuscular disease caused by qualitative or quantitative defects of dystrophin.